United States - English - NLM (National Library of Medicine)

asp cares - testosterone cypionate (unii: m0xw1ubi14) (testosterone - unii:3xmk78s47o) - testosterone cypionate injection, usp is indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone. 1. primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome; or orchidectomy. 2. hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (lhrh) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. safety and efficacy of testosterone cypionate in men with "age-related hypogonadism" (also referred to as "late-onset hypogonadism") have not been established. 1. known hypersensitivity to the drug 2. males with carcinoma of the breast 3. males with known or suspected carcinoma of the prostate gland 4. women who are or who may become pregnant 5. patients with serious cardiac, hepatic or renal disease controlled substa

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cst pharma ltd - testosterone enantate - solution for injection - 250mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - testosterone enantate - solution for injection - 250mg/1ml

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - testosterone undecanoate - solution, sterile - 1000.0 mg/4 ml - testosterone undecanoate 1000.0 mg/4 ml

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - methyltestosterone (unii: v9efu16zif) (methyltestosterone - unii:v9efu16zif) - methyltestosterone 10 mg - androgens are indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone: - primary hypogonadism (congenital or acquired) — testicular failure due to cryptorchidism, bilateral torsions, orchitis, vanishing testis syndrome; or orchidectomy. - hypogonadotropic hypogonadism (congenital or acquired) — gonadotropin or luteinizing hormone-releasing hormone (lhrh) deficiency, or pituitary hypothalamic injury from tumors, trauma, or radiation. (appropriate adrenal cortical and thyroid hormone replacement therapy are still necessary, however, and are actually of primary importance.) if the above conditions occur prior to puberty, androgen replacement therapy will be needed during the adolescent years for development of secondary sexual characteristics. prolonged androgen treatment will be required to maintain sexual characteristics in these and other males who develop testosterone deficiency after puberty. safety and efficacy of methyltestosterone in men with “ag

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - testosterone cipionate 100 mg/ml (101mg with manucturers overage.) - solution for injection - 100 mg/ml - active: testosterone cipionate 100 mg/ml (101mg with manucturers overage.) excipient: benzyl alcohol benzyl benzoate cottonseed oil - depo-testosterone sterile solution is indicated for replacement therapy in males in conditions associated with symptoms of deficiency or absence of endogenous testosterone.

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - testosterone undecanoate - solution for injection - 1000 milligram(s) - 3-oxoandrosten (4) derivatives; testosterone

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - testosterone undecanoate - solution for injection - 250mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

grunenthal ltd - testosterone undecanoate - solution for injection - 250mg/1ml

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading ltd. - testosterone phenylpropionate 60 mg/ml; testosterone decanoate 100 mg/ml; testosterone isocaproate 60 mg/ml; testosterone propionate 30 mg/ml - solution for injection - testosterone propionate 30 mg; testosterone decanoate 100 mg; testosterone phenylpropionate 60 mg; testosterone isocaproate 60 mg - testosterone